Cubist Systematic Strategies, LLC Fibrogen Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.89 - $2.36 $249,343 - $661,179	280,161 Added 3906.86%	287,332 $255,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $3,557 - $13,303	4,873 Added 212.05%	7,171 $16,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $10,919 - $39,116	-13,822 Reduced 85.74%	2,298 $1,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $40,138 - $331,910	16,120 New	16,120 $43,000
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $371,472 - $606,333	-46,785 Reduced 99.29%	335 $4,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $7,139 - $9,973	594 Added 1.28%	47,120 $566,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $1.84 Million - $2.85 Million	-185,018 Reduced 79.91%	46,526 $656,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $2.27 Million - $5.94 Million	223,038 Added 2622.13%	231,544 $2.37 Million
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $185,904 - $357,192	-10,011 Reduced 54.06%	8,506 $227,000
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $395,064 - $710,095	12,744 Added 220.75%	18,517 $643,000
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $1.59 Million - $2.1 Million	-42,832 Reduced 88.12%	5,773 $214,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $692,198 - $778,232	-17,104 Reduced 26.03%	48,605 $2 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $2.14 Million - $2.81 Million	65,709 New	65,709 $2.66 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $886,355 - $1.75 Million	-38,041 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $722,549 - $1 Million	20,895 Added 121.87%	38,041 $1.63 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $634,059 - $830,723	17,146 New	17,146 $634,000
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $213,940 - $255,550	-3,800 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $460,359 - $665,932	-10,253 Reduced 72.96%	3,800 $238,000
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $637,303 - $866,367	14,053 New	14,053 $649,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account